Search
Phenylephrine
go.drugbank.com/drugs/DB00388ApprovedInvestigational[A187370] The action of phenylephrine, or neo-synephrine, was first described in literature in the 1930s.[A187376] Phenylephrine was granted FDA approval in 1939.[L9413] … Phenylephrine is an alpha-1 adrenergic receptor agonist used to treat hypotension,[L9416,L9410] dilate the pupil,[L9413] and induce local vasoconstriction.
Mixtures: Cold and Flu All In One, Doc in the Box All Day SupplyCategories: Compounds used in a research, industrial, or household settingAmiodarone
go.drugbank.com/drugs/DB01118ApprovedInvestigational[A36817] Most known for its approved indication in life-threatening ventricular arrhythmias, it is also used off-label in the outpatient and inpatient setting for atrial fibrillation. … Amiodarone is a benzofuran derivative, anti-arrhythmic drug used commonly in a variety of settings.
Synonyms: 2-n-Butyl-3',5'-diiodo-4'-N-diethylaminoethoxy-3-benzoylbenzofuranInternational brands: Amio-Aqueous IVVitamin D
go.drugbank.com/drugs/DB11094ApprovedInvestigationalNutraceuticalVet approvedVitamin D3 and D2 require hydroxylation in order to become biologically active in the human body. … in opposition to parathyroid hormone.
Mixtures: Vc II, Formula InfProducts: Vitamin D 1000 Iu TabletsSodium acetate
go.drugbank.com/drugs/DB09395ApprovedInvestigationalSodium acetate could be used as additives in food, industry, concrete manufacture, heating pads and in buffer solutions. … It can be used also in metabolic acidosis and for urine alkalinization.
Mixtures: NUTRIPLUS LIPID SENZA ELETTROLITI, NUTRIPLUS LIPID SENZA ELETTROLITIProducts: Sodium Acetate Inj 328mg/ml USPTemozolomide
go.drugbank.com/drugs/DB00853ApprovedInvestigationalIt is currently marketed under the trademark TEMODAR® by Merck.[L32033] … [A229848, A229858, L32033] Temozolomide is an imidazotetrazine prodrug that is stable at acidic pH but undergoes spontaneous nonenzymatic hydrolysis at neutral or slightly basic pH; these properties allow
Products: TEMODAL 140MG HKP IN BTL, TEMODAL 180MG HKP IN BTLSelenious acid
go.drugbank.com/drugs/DB11127ApprovedOne study showed efficacy in the prevention of malignancy while utilizing a selenium supplement in humans. … It also plays an important role in maintaining the general health of tissue and muscle and has antioxidant properties.
Mixtures: Tracel Injektionslösung in einer Fertigspritze, Vc IIProducts: Selepen Inj 40mcg/ml USPGadopentetic acid
go.drugbank.com/drugs/DB00789ApprovedInvestigationalA complex of gadolinium with a chelating agent, diethylenetriamine penta-acetic acid (DTPA see pentetic acid), that is given to enhance the image in cranial and spinal MRIs.
Categories: Compounds used in a research, industrial, or household settingProducts: EMARAY IV ENJEKSIYONLUK COZELTI ICEREN FLAKON 10 ML, EMARAY IV ENJEKSIYONLUK COZELTI ICEREN FLAKON 15 MLLevofloxacin
go.drugbank.com/drugs/DB01137ApprovedInvestigational[A31453,A190756] Levofloxacin was first approved by the FDA in 1996, and was approved in Canada and several South American countries soon after.[A190663] … " due to improved activity against gram-positive bacteria commonly implicated in respiratory infections.
Categories: Topoisomerase II InhibitorsProducts: Levofloxacin In 5% Dextrose Injection, Cravit IV 5mg/mlPentoxifylline
go.drugbank.com/drugs/DB00806ApprovedInvestigational[A226608] Pentoxifylline has been marketed in Europe since 1972; PTX extended-release tablets sold under the trade name TRENTAL by US Pharm Holdings were first approved by the FDA on Aug 30, 1984, but … its possible use in diverse conditions, including osteoradionecrosis, diabetic kidney disease, and generally any condition associated with fibrosis.
International brands: Ao Le Ni, An Ruo NingCategories: Compounds used in a research, industrial, or household settingAntihemophilic factor (recombinant), PEGylated
go.drugbank.com/drugs/DB09329ApprovedInvestigationalPEGylation decreases factor VIII clearance and allowing for an increased duration of drug circulation in the plasma [L1529]. … Antihemophilic Factor (Recombinant), PEGylated, was approved by the FDA in December 2016 as the product _Adynovate_ [FDA label].
Categories: Compounds used in a research, industrial, or household settingProducts: ADYNOVATE 500®IU / VIAL, ADYNOVATE 3000 IU POWDER AND SOLVENT FOR SOLUTION FOR INJECTION